Corey Fussell
Family Medicine · Eatonton, GANPI 1497103824
Payments from drug & device makers
Across 132 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$632
- AstraZeneca$166
- AbbVie$160
- GSK$155
- Boehringer Ingelheim$153
- Pfizer$144
- plus $620 from 13 others
What the payments were for
- Food & beverage$2,031100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $632 |
| AstraZeneca | 10 | $166 |
| AbbVie(2 entities) | 10 | $160 |
| GSK | 10 | $155 |
| Boehringer Ingelheim | 9 | $153 |
| Pfizer | 9 | $144 |
| Zealand Pharma US, Inc. | 7 | $120 |
| Amgen | 6 | $87 |
| Merck | 5 | $81 |
| Sanofi-aventis U.S. LLC | 5 | $66 |
| Mylan Specialty L.p. | 4 | $61 |
| Lilly USA, LLC | 3 | $44 |
| Dexcom, Inc. | 2 | $36 |
| Bayer | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Exact Sciences | 1 | $24 |
| Eisai Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
How this compares
$2,031 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $35,574 |
| OzempicSemaglutide | 15 | $29,247 |
| MounjaroTirzepatide | 15 | $21,957 |
| FarxigaDapagliflozin Propanediol | 27 | $20,559 |
| EliquisApixaban | 11 | $14,109 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $7,528 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 170 | $3,385 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 219 | $3,007 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 12 | $2,677 |
| Rosuvastatin Calcium | 61 | $1,519 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 66 | $1,334 |
| Atorvastatin Calcium | 75 | $1,210 |
| Ezetimibe | 13 | $938 |
| Omeprazole | 45 | $842 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 12 | $831 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Shingrix | $155 | $38,25146 claims |
| Novo NordiskOzempic | $632 | $29,24715 claims |
| Lilly USA, LLCMounjaro | $44 | $21,95715 claims |
| AstraZenecaFarxiga | $166 | $20,55927 claims |
| PfizerEliquis | $144 | $14,10911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Eatonton
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.